AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

PEPTECH ENTERS INTO JV TO DEVELOP BIOTECH PRODUCTS.

AsiaPulse News

| December 01, 2003 | COPYRIGHT 2003 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

SYDNEY, Dec 1 Asia Pulse - Four new products are to be developed by biotech Peptech Ltd (ASX:PTD), in a new joint venture with fellow biotech Biosceptre International Ltd.

Peptech said four distinct products had been identified for development by the joint venture, two with diagnostic applications to confirm the presence of cancer and two with therapeutic applications.

Both companies will share equally in commercialisation benefits of all products.

Peptech executive chairman Mel Bridges said Peptech would be responsible for the development of a diagnostic and therapeutic application, while Biosceptre would develop the other two applications.

Peptech paid $3.5 million to Biosceptre to obtain the exclusive licence for the intellectual property for the two products that it will develop.

In return, Biosceptre used the money to buy 2.3 million shares in Peptech at ...

Related articles from newspapers, magazines, journals, and more
PEPTECH REALISES A$178 MLN ON DOMANTIS GSK DEAL.
News wire article from: AsiaPulse News December 11, 2006 700+ words
...group, had it occurred on 30 September 2006. SOURCE: Peptech Limited CONTACT: Peptech Limited ABN 98 002 951 877 19-25 Khartoum Rd Macquarie...9870 8788 Facsimile +61 2 9870 8786 WEBSITE: www.peptech.com ASIA PULSE 11-12 1226
AUSTRALIA'S PEPTECH, US CENTOCOR PATENT DISPUTE RAVAGES SHARES.
News wire article from: AsiaPulse News February 18, 2003 700+ words
MELBOURNE, Feb 18 Asia Pulse - Shares in biotech Peptech Ltd (ASX:PTD) dived...be paying royalties to Peptech on the basis that its Remicade...product did not fall under Peptech's anti-TNF patents. ASIA PULSE a 18-02 1103
SHARES IN AUSTRALIA'S PEPTECH UP 54% AFTER PARTNER GETS FDA NOD.
News wire article from: AsiaPulse News January 2, 2003 700+ words
SYDNEY, Jan 2 Asia Pulse - Shares in biotech Peptech Ltd (ASX:PTD) catapulted...future demand for HUMIRA," Peptech said. Peptech said Abbott was also expected...Products, in the middle of 2003. ASIA PULSE 02-01 2039
AUSTRALIA'S PEPTECH DEVELOPING ANTIBODIES THAT DRUG COS WANT.
News wire article from: AsiaPulse News February 15, 2006 700+ words
SYDNEY, Feb 15 Asia Pulse - Drug developer Peptech Ltd (ASX:PTD) says...seven quality assets, Peptech currently had "multiple...institutional investors. Peptech shares ended up 2.5 cents at A$1.435. ASIA PULSE 15-02 1716
CITIGROUP TO ADVISE PEPTECH ON APPROACHES BY PRIVATE EQUITY COS.
News wire article from: AsiaPulse News March 14, 2007 700+ words
SYDNEY, March 14 Asia Pulse - Biotechnology company Peptech Ltd (ASX:PTD) has appointed...Investment Banking will advise Peptech on a "broad range of strategic...in its business", it said. Peptech told shareholders at its annual...
PEPTECH REALISES A$178M WITH DOMANTIS SALE COMPLETION.
News wire article from: AsiaPulse News January 8, 2007 700+ words
...exchange rate of 0.4000 has been used. About Peptech: Peptech Limited focuses on the research and development of peptides...biopharmaceutical development. For further information: www.peptech.com SOURCE: Peptech ASIA PULSE 08-01 1310
AUSTRALIA'S PEPTECH SHARES PLUNGE 25% AFTER DISPUTE ANNOUNCEMENT.
News wire article from: AsiaPulse News February 19, 2003 700+ words
MELBOURNE, Feb 19 Asia Pulse - Shares in biotech Peptech Ltd (ASX:PTD) plunged...be paying royalties to Peptech on the basis that its Remicade...product did not fall under Peptech's anti-TNF patents. ASIA PULSE 19-02 1340
AUSTRALIA'S PEPTECH SELLS DOMANTIS STAKE TO GLAXOSMITHKLINE.
News wire article from: AsiaPulse News January 8, 2007 700+ words
SYDNEY, Jan 8 Asia Pulse - Peptech Ltd (ASX:PTD) has sold its stake...which has bought all of Domantis. Peptech said it would realise a gain of...said the transaction would enable Peptech to build on its acquisitions of Promics...
For more facts and information, see all results

Source: HighBeam Research, PEPTECH ENTERS INTO JV TO DEVELOP BIOTECH PRODUCTS.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA